Overview

Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization Cycle

Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
This goal of this study is to evaluate the outcomes from in vitro fertilization cycles where a 450 IU daily dose of gonadotropins is administered compared to those where a 600 IU daily dose is administered for women who are at risk of a poor ovarian response in order to determine if one dose or the other results in improved cycle outcomes.
Phase:
Phase 3
Details
Lead Sponsor:
Clinique Ovo
OVO R & D
Collaborator:
Ferring Pharmaceuticals
Treatments:
Menotropins